---
title: HCT-116-luc Orthotopic Model - TD2 Precision Oncology
description: HCT-116-luc is a luminescent colon cancer cell line used for studying tumor growth and testing therapeutic interventions.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/hct-116-luc.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# HCT-116-luc Orthotopic Model
**Synonyms:** –
HCT-116-luc is a luminescent colon cancer cell line derived from HCT-116. It expresses luciferase, allowing for non-invasive monitoring of tumor growth and response to therapies using bioluminescence imaging techniques. HCT-116-luc serves as a valuable tool for studying colon cancer, evaluating drug efficacy, and investigating therapeutic approaches. Researchers utilize this cell line to explore colon cancer biology, identify novel targets, and test anti-cancer agents in preclinical studies.
## Model Details
**Cancer Type:** -B-
**Model Name:** HCT-116-luc
**Mouse Strain:** CB.17 SCID
**Treatment Data Available:** N/A
## HCT-116-luc Growth curves
Growth of HCT-116-luc after IP disseminated injection of CB.17 SCID mice (n=5)
### Request Additional Syngeneic Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)